PRHSX : T. ROWE PRICE HEALTH SCIENCES

1
 
 
 
 

ZACKS RANK: 1 - STRONG BUY

Ticker: PRHSX
Manager: Taymour R. Tamaddon
Manager Since: 12/13
NAV (04/18/2014): 57.93
Objective: Equity - Sector Health
Peer: HL MG
Net Assets ($mil): 8578.00
Inception: 12/29/1995
PRHSX : Description

The fund was incepted in December 1995 and is managed by T.Rowe Price Associates. This health fund's main objective is long-term capital appreciation. The fund invests at least 80% of its net assets in common stocks of companies engaged in the research, development, production, or distribution of products or services related to health care, medicine, or the life sciences. The fund may invest in companies of any size, the majority of fund assets are invested in large and mid capitalization companies. Dividends and capital gains, if any, are declared annually in December.

PRHSX : Composition - 04/14
Stocks 97.59%
Foreign Stocks 10.43%
Cash 2.29%
Bonds 0.00%
Foreign Bonds 0.00%
Preferred 0.04%
Convertible 0.14%
Other -0.06%
Foreign Hedged 0.00%
Composition Horizontal Bar Chart
PRHSX : Style Analysis - 04/14
Large Growth 22.40%
Large Value 0.00%
Small Growth 3.94%
Small Value 0.00%
Foreign Stock 22.40%
Emerging Market 0.00%
Precious Metals 0.00%
Intermediate Bond 0.00%
High Yield Bond 16.95%
Foreign Bond 32.86%
Style Analysis Horizontal Bar Chart
PRHSX : Risk Analysis
Beta v. S&P 500 0.85
Beta v. EAFE 0.11
Beta v. Barclays Agg Bond 0.69
Alpha 3 Yr 13.06
Alpha 5 Yr 11.40
R-Sq 3 Yr 0.57
R-Sq 5 Yr 0.57
Std Dev 3 Yr 15.47
Std Dev 5 Yr 15.46
Sharpe 3 Yr 1.89
Sharpe 5 Yr 2.03
PRHSX : Fees
Expense Ratio 0.79
% Max Load NA
% Min Load NA
% Deferred Load NA
% Redemption NA
% Max 12 B1 Fee 0.00
% Max Mgt Fee 0.65
PRHSX : Purchase Choices:
Min Initial Investment 2500
Min Subsequent Investment 100
PRHSX : Returns Analysis - Annual

Line chart

  2004200520062007200820092010201120122013YTD
NAV ($) 23.1125.0726.1328.3219.8026.1730.2832.6041.2257.8057.93
Total Return (%) 15.8413.539.5718.74-28.7732.1716.3211.0031.9351.395.98
Annual Dividend Yield (%) 0.000.000.000.000.000.000.000.000.300.000.00
Relative Performance
Rel Performance-S&P500(%) 49.6786.42-62.17132.5282.3757.5112.6289.07159.41190.1441.86
Rel Performance-Obj.Ret.(%) 70.6045.7058.4498.82-50.74102.9583.0132.58127.0250.88-8.29
Ret.Quintile vs Obj(1 is best) 12215111123
Turnover, Yields, and Gains
Fund Assets Net($mil) 1,3291,3421,7142,2951,7002,1572,4833,0735,0168,5788,578
Annual Turnover (%) 44.1055.7048.8044.8047.4033.4036.4023.3012.9045.700.00
Annual Dividend Paid ($) 0.000.000.000.000.000.000.000.000.140.000.00
Annual Capital Gains Paid($) 0.001.161.342.680.340.000.160.961.674.430.00
PRHSX : Returns Analysis - Trailing Total Return
  1 Month 3 Month 6 Month YTD 1 Year 3 Year 5 Year 10 Year 15 Year 20 Year
Total Return (through 04/14) -5.79% 5.98% 15.28% 5.98% 39.39% 27.85% 30.10% 15.02% 13.61% NA
Ret. Percentile vs. Obj. (1 is best) 73 57 49 57 33 20 7 7 2 NA
PRHSX : Stock Portfolio Snapshot - 04/14
Average Price/Earnings 27.32
Average Price/Book 4.62
Average EPS Growth 15.24
Average Market Value 32,442.00
PRHSX : Stock Sector Breakout - 04/14
Stock Sector Breakout
PRHSX : Top Holdings - 04/14
Name Weight Shares
GILEAD SCIENCES INC 7.60 8,673,000
ALEXION PHARMACEUTICALS INC 4.53 2,919,100
BIOGEN IDEC INC 3.13 961,200
UNITEDHEALTH GROUP INC 2.97 3,386,700
PHARMACYCLICS INC 2.53 2,052,700
AGILENT TECHNOLOGIES INC 2.89 4,327,830
INCYTE PHARMACEUTICALS INC 2.87 4,855,600
MCKESSON CORP 2.65 1,409,800
VALEANT PHARMACEUTICALS 2.95 2,157,600